Patents by Inventor Eric Rimmer

Eric Rimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for soluble PD-L1
    Patent number: 9535074
    Abstract: The present disclosure describes two matched antibody pairs for use in a sandwich immunoassay for detecting and quantifying soluble PD-L1 in liquid samples, as well as an electrochemiluminescence sandwich immunoassay that has been optimized and validated with one of the matched pairs.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: January 3, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Gulesi Ayanoglu, Xiaoyan Du, Jr., Vinita Gupta, Omar Laterza, Linda Liang, Eric Rimmer
  • IMMUNOASSAY FOR SOLUBLE PD-L1
    Publication number: 20160069900
    Abstract: The present disclosure describes two matched antibody pairs for use in a sandwich immunoassay for detecting and quantifying soluble PD-L1 in liquid samples, as well as an electrochemiluminescence sandwich immunoassay that has been optimized and validated with one of the matched pairs.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 10, 2016
    Inventors: Gulesi Ayanoglu, Xiaoyan Du, JR., Vinita Gupta, Omar Laterza, Linda Liang, Eric Rimmer
  • AraC in combination with a cytokine-secreting cell and methods of use thereof
    Publication number: 20080267935
    Abstract: The present invention provides improved method of cancer therapy in a mammal. More particularly, the invention is concerned with systems comprising cytosine arabinoside (AraC) and a cytokine-expressing cancer immunotherapy composition and methods of administering the combination to cancer patients in order to generate an immune response against the cancer and provide treatment with therapeutic efficacy that is an improvement relative to administration of AraC or the cytokine-expressing cancer immunotherapy composition alone as a monotherapy.
    Type: Application
    Filed: April 4, 2008
    Publication date: October 30, 2008
    Applicant: Cell Genesys, Inc.
    Inventors: JianMin Lin, Betty Li, Eric Rimmer, Melinda Van Roey, Karin Jooss